发明名称 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE
摘要 Monoclonal neutralizing antibodies are disclosed that specifically bind to the HIV-1 gp41 membrane-proximal external region (MPER). Also disclosed are compositions including the disclosed antibodies that specifically bind gp41, nucleic acids encoding these antibodies, expression vectors including the nucleic acids, and isolated host cells that express the nucleic acids. The antibodies and compositions disclosed herein can be used for detecting the presence of HIV-1 in a biological sample, or detecting an HIV-1 infection or diagnosing AIDS in a subject. In additional, the broad neutralization breadth of the disclosed antibodies makes them ideal for treating a subject with an HIV infection. Thus, disclosed are methods of treating and/or preventing HIV infection.
申请公布号 US2016333076(A1) 申请公布日期 2016.11.17
申请号 US201615226744 申请日期 2016.08.02
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Serv 发明人 Connors Mark;Huang Jinghe;Laub Leo B.;Kwong Peter;Nabel Gary;Mascola John R.;Zhang Baoshan;Rudicell Rebecca S.;Georgiev Ivelin;Yang Yongping;Zhu Jiang;Ofek Gilad
分类号 C07K16/10;G01N33/569 主分类号 C07K16/10
代理机构 代理人
主权项 1. An isolated nucleic acid molecule encoding a human monoclonal antibody, the antibody comprising: a heavy chain variable region comprising a heavy chain complementarity determining region (HCDR)1, a HCDR2, and a HCDR3 comprising amino acids 26-33, 51-60, and 99-120 of SEQ ID NO: 1, respectively; and a light chain variable region comprising a light chain complementarity determining region (LCDR)1, a LCDR2, and a LCDR3, comprising amino acids 26-31, 49-51, and 88-99 of SEQ ID NO: 2, respectively; wherein the antibody specifically binds gp41 and neutralizes HIV-1.
地址 Bethesda MD US